Showing results (211-220 of 254) with videos related to

Sort By:
Pageof 26
Alimentary Pharmacology & Therapeutics|February 1, 1994
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)R Caprilli, A Andreoli, L Capurso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 12, 2002
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide studyA Viscido, V Bagnardi, G C Sturniolo, et al.
Cytometry|April 20, 2001
Increased myeloperoxidase index and large unstained cell values can predict the neutropenia phase of cancer patients treated with standard dose chemotherapyA Bononi, F Lanza, M Dabusti, et al.
Cancer|January 15, 1996
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical ResearchV De Lisi, G Cocconi, F Angelini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2012
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysisR Bellocco, E Pasquali, M Rota, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trialR Caprilli, M Cottone, F Tonelli, et al.
The American Journal of Gastroenterology|July 14, 2000
Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, G Palumbo, et al.
Gut|June 1, 1994
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence valuesG Corrao, G R Corazza, M L Andreani, et al.
Alimentary Pharmacology & Therapeutics|May 8, 1999
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, A Andreoli, et al.
American Journal of Clinical Oncology|February 20, 1999
Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II studyF Recchia, A Lococo, C Campisi, et al.
Pageof 26